Related Experiment Video
Updated: Mar 20, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
5.4K
[Optimizing medication intake in patients with chronic liver disease]
Stefanie Lacher1,2, Silvia Rusch1, Diana Staudacher1
11 UniversitätsSpital Zürich.
Pflege
|May 24, 2016
Summary
Improving medication adherence in chronic liver disease patients is crucial. Family caregivers and healthcare professionals can enhance adherence through information, support, and practical strategies, reducing disease progression and costs.
Area of Science:
- Hepatology
- Patient Adherence Research
- Healthcare Management
Context:
- Non-adherence to medication in chronic liver disease (CLD) patients leads to severe health consequences and increased healthcare expenses.
- Family caregivers play a vital role in supporting patients with CLD.
- Optimizing medication adherence is essential for managing CLD effectively.
Purpose:
- To develop a practical work instruction to improve medication adherence in patients with chronic liver disease and their family caregivers.
- To integrate evidence-based adherence-enhancing interventions into clinical practice.
Summary:
- Utilizing participatory action research and systematic literature review, interventions were identified to improve medication adherence in CLD patients.
- Key findings indicate that providing information, fostering supportive relationships with healthcare professionals, effective communication, memory aids, and integrating medication into daily routines are beneficial.
- Patient experiences and nursing clinical insights informed the development of practical, context-specific strategies.
Impact:
- The developed work instruction aims to bridge the gap between research findings and clinical practice.
- Implementation of this work instruction is expected to enhance medication adherence, thereby improving patient outcomes and potentially reducing healthcare costs associated with CLD.
- This initiative supports healthcare professionals in optimizing care for CLD patients and their families.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
329
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
329
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
331
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
331
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
249
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
298
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
298
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
283
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
283
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.8K